Építés alatt – nem éles oldal
Belépés
Befejeződött1. fázis

Randomized, non-comparative, open-label early phase Ib study with OBT076 or OBT076 followed by Balstilimab in patients with Adenoid Cystic Carninoma of the Head and Neck

Key facts

Where
Avignon, Bordeaux, Caen Cedex 5, Clermont-Ferrand, Lille, Lyon, Marseille, Montpellier Cedex 5, Nice Cedex 2, Pierre-Bénite, St Herblain, Strasbourg, Toulouse, Tours Cedex 9, Vandoeuvre Les Nancy_ Cedex és Villejuif, FranciaországSee the 16 sites
Phase
1. fázis

Where in Franciaország

  • Institut Sainte-CatherineAvignon, FranciaországNo longer taking part
  • Centre hospitalier Universitaire de BordeauxBordeaux, FranciaországNo longer taking part
  • Centre Francois BaclesseCaen Cedex 5, FranciaországNo longer taking part
  • Centre Jean PerrinClermont-Ferrand, FranciaországNo longer taking part
  • Centre Oscar LambretLille, FranciaországNo longer taking part
  • Centre Leon BerardLyon, FranciaországNo longer taking part
  • Assistance Publique Hôpitaux de MarseilleMarseille, FranciaországNo longer taking part
  • Institut Regional Du Cancer De MontpellierMontpellier Cedex 5, FranciaországNo longer taking part
  • Centre Antoine LacassagneNice Cedex 2, FranciaországNo longer taking part
  • Centre Hospitalier Lyon-SudPierre-Bénite, FranciaországNo longer taking part
  • Institut De Cancerologie De L OuestSt Herblain, FranciaországNo longer taking part
  • Institut de Cancérologie Strasbourg EuropeStrasbourg, FranciaországNo longer taking part
  • Institut Claudius RegaudToulouse, FranciaországNo longer taking part
  • Centre Hospitalier Regional Universitaire De ToursTours Cedex 9, FranciaországNo longer taking part
  • Institut de cancérologie de LorraineVandoeuvre Les Nancy_ Cedex, FranciaországNo longer taking part
  • Institut Gustave RoussyVillejuif, FranciaországNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Groupe Oncologie Radiotherapie Tete Cou
Trial code
EU 2023-503270-20-00
Record updated
2024. június 3.